Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
|
| gptkbp:affects |
humans
|
| gptkbp:alsoKnownAs |
gptkb:Type_2_Diabetes
gptkb:T2DM |
| gptkbp:cause |
blindness
amputation |
| gptkbp:characterizedBy |
insulin resistance
relative insulin deficiency |
| gptkbp:complication |
gptkb:cardiovascular_disease
stroke kidney failure peripheral neuropathy retinopathy foot ulcers |
| gptkbp:diagnosedBy |
gptkb:oral_glucose_tolerance_test
HbA1c test fasting blood glucose test |
| gptkbp:firstDescribed |
20th century
|
| gptkbp:hasGeneticComponent |
yes
|
| https://www.w3.org/2000/01/rdf-schema#label |
Diabetes Mellitus, Type 2
|
| gptkbp:ICD-10_code |
E11
|
| gptkbp:managedBy |
endocrinologist
primary care physician |
| gptkbp:onset |
usually adulthood
|
| gptkbp:prevalence |
increasing worldwide
most common form of diabetes |
| gptkbp:prevention |
healthy diet
maintaining healthy weight regular physical activity |
| gptkbp:relatedTo |
gptkb:Diabetes_Mellitus,_Type_1
gptkb:gestational_diabetes |
| gptkbp:riskFactor |
family history
obesity ethnicity physical inactivity older age unhealthy diet |
| gptkbp:symptom |
fatigue
blurred vision frequent urination increased thirst increased hunger slow-healing sores |
| gptkbp:treatment |
gptkb:metformin
gptkb:insulin gptkb:GLP-1_receptor_agonists gptkb:SGLT2_inhibitors lifestyle modification oral hypoglycemic agents sulfonylureas |
| gptkbp:bfsParent |
gptkb:D004053
gptkb:D003371 gptkb:D003700 gptkb:D004481 |
| gptkbp:bfsLayer |
7
|